1
Return

Cardiac myosin-binding protein C in ST-elevation myocardial infarction

delete2026-03-01
delete0
PRE
AI
R
Ramyah Rajakulasingam
B
Bashir Alaour
S
Sam Whitman McGrath
L
Liam S. Couch
Y
Yamam Sbeih
Z
Zohya Khalique
E
Emanuela Falaschetti
A
Alexander Tindale
E
Emily-Jane Cantor
C
Catherine Beattie
M
Miles C. Dalby
D
Dudley J. Pennell
M
Michael Marber
R
Ranil de Silva *
DOI:10.1093/ehjacc/zuag032delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Aims Cardiac myosin-binding protein C (cMyC) is a novel biomarker of myocardial injury, rising and falling more rapidly than cardiac troponins in myocardial infarction (MI), potentially enabling earlier diagnosis. Its performance has not been assessed in reperfused acute ST-segment elevation myocardial infarction (STEMI), against gold-standard biochemical (high-sensitivity cardiac troponin I, hs-cTnI) or imaging (cardiovascular magnetic resonance, CMR) biomarkers. This study tested the hypotheses that: i) cMyC correlates with acute and final MI size by late gadolinium enhancement (LGE) CMR and ii) cMyC is related to the presence of acute microvascular obstruction (MVO) by CMR. Methods and results Blood samples were obtained at 6 +/- 2 hourly intervals for 24 hours (hrs) for measurement of hs-cTnI and cMyC concentrations in patients with reperfused acute STEMI. Patients underwent 3T LGE-CMR at similar to 3-5 days (n = 69) and similar to 4 months (n = 65) after reperfusion. Acute cMyC at all timepoints significantly correlated with acute and final MI size on LGE-CMR, most strongly at 6-hrs post reperfusion (r = 0.7, P < 0.001). cMyC at 6-, 12-, 18- and 24-hrs demonstrated significant discriminatory power in identifying patients with acute MVO, with the 6-hr level having the highest discriminative power. Hs-cTnI correlated more strongly with acute and final MI size compared with cMyC and had significantly higher discriminatory ability in identifying MVO at 12-, 18- and 24-hrs. Conclusion cMyC is a quantitative biochemical biomarker of myocardial injury in reperfused STEMI. Further studies, using optimised high-sensitivity assays, are warranted to evaluate its potential as a novel biomarker after acute MI.
Keywords:
Cardiac myosin-binding protein C
High-sensitivity cardiac troponin I
ST-elevation myocardial infarction
Myocardial infarction size
Microvascular obstruction
Myocardial injury

Journal

European Heart Journal-Acute Cardiovascular Care cover
European Heart Journal-Acute Cardiovascular Care
IF:
4.6
Papers:
1.4K
Citations:
3.2K

Organization

R
royal brompton & harefield nhs foundation trust
Scholars:
98
Papers: 48
Citations: 0
I
imperial college london
Scholars:
8.3K
Papers: 3.8K
Citations: 0
R
Royal Brompton Hospital
Scholars:
5.2K
Papers: 4.3K
Citations: 3.9K
Harefield Hospital cover
Harefield Hospital
Scholars:
940
Papers: 700
Citations: 1.9K
Cited Papers

Cited Papers

Citing Papers

Citing Papers